Status:

COMPLETED

Resilience in Young Adults Newly Diagnosed With Multiple Sclerosis

Lead Sponsor:

Universita di Verona

Collaborating Sponsors:

Azienda Ospedaliera Universitaria Integrata Verona

Fondazione Italiana Sclerosi Multipla

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18-45 years

Brief Summary

This study aims to fill the gap of knowledge on the biopsychosocial (BPS) characteristics and resilience of young adults newly diagnosed with Multiple Sclerosis, to evaluate the relationship among the...

Detailed Description

Multiple sclerosis (MS) is the most common neurological disease causing disability in young adults and is widely recognized as a major stress factor. Several studies have shown that the first years af...

Eligibility Criteria

Inclusion

  • MS diagnosis in the 2 years prior to study inclusion, according to the revised McDonald Criteria (Thompson et al., 2018);
  • MRI of the brain in the 6 months prior to or within one month after screening visit according to a standardized protocol (including pre- and post-contrast volumetric T1-weighted, 3D Fluid Attenuated Inversion Recovery (FLAIR), and 3D Double Inversion Recovery (DIR) sequences for brain imaging, and sagittal and axial pre- and post-contrast volumetric T1-weighted, T2-weighted and short tau inversion recovery (STIR) sequences for spinal cord imaging)
  • Italian speakers.

Exclusion

  • Clinically relevant cognitive deficits as evaluated by the treating neurologist
  • Treatment with any disease-modifying therapy (DMT) for MS at inclusion and by completion of study procedures (maximum two months from consent); steroids administration up to 30 days prior to inclusion is allowed.

Key Trial Info

Start Date :

February 26 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 31 2022

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT03825055

Start Date

February 26 2019

End Date

March 31 2022

Last Update

November 15 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Azienda Ospedaliera Universitaria Integrata Verona, Policlinico G.B. Rossi

Verona, Veneto, Italy, 37134

Resilience in Young Adults Newly Diagnosed With Multiple Sclerosis | DecenTrialz